VanEck Associates’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$176M Buy
433,766
+43,051
+11% +$17.5M 0.2% 107
2025
Q1
$194M Sell
390,715
-27,650
-7% -$13.8M 0.25% 100
2024
Q4
$218M Buy
418,365
+68,927
+20% +$35.9M 0.28% 87
2024
Q3
$201M Buy
349,438
+5,721
+2% +$3.3M 0.25% 99
2024
Q2
$190M Sell
343,717
-31,057
-8% -$17.2M 0.27% 94
2024
Q1
$218M Buy
374,774
+22,557
+6% +$13.1M 0.33% 81
2023
Q4
$187M Buy
352,217
+339,013
+2,568% +$180M 0.34% 79
2023
Q3
$6.68M Sell
13,204
-1,954
-13% -$989K 0.01% 428
2023
Q2
$7.91M Buy
15,158
+991
+7% +$517K 0.02% 395
2023
Q1
$8.17M Buy
14,167
+1,533
+12% +$884K 0.02% 382
2022
Q4
$6.96M Sell
12,634
-190
-1% -$105K 0.02% 404
2022
Q3
$6.5M Sell
12,824
-333
-3% -$169K 0.02% 383
2022
Q2
$7.15M Sell
13,157
-2,390
-15% -$1.3M 0.02% 382
2022
Q1
$9.18M Sell
15,547
-1,470
-9% -$868K 0.02% 378
2021
Q4
$11.4M Sell
17,017
-172,193
-91% -$115M 0.03% 349
2021
Q3
$108M Sell
189,210
-5,431
-3% -$3.1M 0.27% 94
2021
Q2
$98.2M Buy
194,641
+189,478
+3,670% +$95.6M 0.23% 112
2021
Q1
$2.36M Buy
5,163
+201
+4% +$91.7K 0.01% 572
2020
Q4
$2.31M Buy
4,962
+875
+21% +$408K 0.01% 520
2020
Q3
$1.8M Sell
4,087
-6,181
-60% -$2.73M 0.01% 516
2020
Q2
$3.72M Sell
10,268
-3,139
-23% -$1.14M 0.01% 379
2020
Q1
$3.8M Sell
13,407
-2,923
-18% -$829K 0.02% 368
2019
Q4
$5.31M Sell
16,330
-4,257
-21% -$1.38M 0.02% 361
2019
Q3
$6M Buy
20,587
+646
+3% +$188K 0.03% 306
2019
Q2
$5.86M Buy
19,941
+1,749
+10% +$514K 0.03% 296
2019
Q1
$4.98M Sell
18,192
-4,689
-20% -$1.28M 0.02% 304
2018
Q4
$5.12M Buy
22,881
+2,082
+10% +$466K 0.03% 302
2018
Q3
$5.08M Buy
20,799
+1,600
+8% +$391K 0.02% 320
2018
Q2
$3.98M Buy
+19,199
New +$3.98M 0.02% 339